Tech Company Financing Transactions

Vaccsys Funding Round

Vaccsys closed a $9 million Series A investment round on 6/18/2008. Backers included Alta Partners, The Column Group and Versant Ventures.

Transaction Overview

Company Name
Announced On
6/18/2008
Transaction Type
Venture Equity
Amount
$9,000,000
Round
Series A
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
1124 Columbia St 402
Seattle, WA 98104
USA
Email Address
Overview
The company is developing vaccines that regulate immune responses by targeting dendritic cell biology with combinations of proprietary vectors and adjuvants.
Profile
Vaccsys LinkedIn Company Profile
Social Media
Vaccsys Company Twitter Account
Company News
Vaccsys News
Facebook
Vaccsys on Facebook
YouTube
Vaccsys on YouTube

Management Team

Title
Name
Email & Social
   LinkedIn Profile   Twitter Account   News   on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/18/2008: DynaPump venture capital transaction
Next: 6/18/2008: ParaScale venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary